L-kynurenine as a prognostic marker for early mortality in patients with acute 
myeloid leukemia

Kierdorf, Fiona; Zimmer, Philipp; Joisten, Niklas; Kiesl, David; Winker, Matteo; Rigoux, Lionel; Elter, Thomas

doi:10.1080/10428194.2022.2053534

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia

MPS-Authors

/persons/resource/persons183321

Rigoux, Lionel
Translational Neurocircuitry, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kierdorf, F., Zimmer, P., Joisten, N., Kiesl, D., Winker, M., Rigoux, L., et al. (2022). L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia. Leukemia and Lymphoma, 63(8): 2053534, pp. 2001-2004. doi:10.1080/10428194.2022.2053534.

Cite as: https://hdl.handle.net/21.11116/0000-000A-540E-9

Abstract

There is no abstract available